Onychomycosis Treatment Market Report 2023: Size, Share, Growth, Outlook and Forecast 2028

According to the latest report by IMARC Group, titled “Onychomycosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the onychomycosis treatment market share. The global onychomycosis treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.37% during 2023-2028.

Onychomycosis refers to a fungal condition in the fingernails and toenails that can lead to chronic pain, discomfort, and disfigurement. Common types of infections include proximal subungual, white superficial, and distal subungual. Onychomycosis is a common nail infection in patients with athlete’s foot and is caused by various organisms, such as yeasts, dermatophytes, and non-dermatophyte molds. It is characterized by symptoms, including foul smell, distortion in the shape of nails, whitish to yellow-brown discoloration, brittle, ragged, and crumbly texture of the nails, etc. Onychomycosis is usually diagnosed through potassium, oxygen, and hydrogen (KOH) examination, culture, and histopathological reevaluations of nail clippings and nail biopsies and is treated through drugs, laser therapy, and photodynamic cures.

Request for a free sample copy of this report: https://www.imarcgroup.com/onychomycosis-treatment-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Market Trends:

The escalating prevalence of chronic medical ailments, such as human immunodeficiency virus (HIV), diabetes, and peripheral artery disease (PAD), is primarily driving the onychomycosis market. Besides this, the increasing geriatric population, which is highly prone to circulatory disorders and weakened immune systems, is further augmenting the market growth. Moreover, the rising utilization of tight, contaminated, or soiled clothes, shoes, and socks, especially by millennials, is also catalyzing the global market. Apart from this, the development of water-soluble antifungal treatment solutions that can be administered orally is acting as another significant growth-inducing factor. Furthermore, the rising usage of topical nail lacquers and ointments to maintain nail hygiene and the expanding healthcare infrastructure are anticipated to propel the onychomycosis market over the forecasted period.

Breakup by Disease Type:

  • Distal Subungual Onychomycosis

  • Proximal Subungual Onychomycosis

  • White Superficial Onychomycosis

  • Candidal Onychomycosis

  • Others

Breakup by Treatment Type:

  • Laser Therapy

  • Photodynamic Therapy

  • Drug Treatment

Breakup by Drug Class:

  • Allylamine

  • Azole

  • Griseofulvin

  • Others

Breakup by Distribution Channel:

  • Hospitals and Clinics

  • Online Stores

  • Retail Pharmacies

  • Others

Breakup by Region:

  • North America (United States, Canada)

  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Latin America (Brazil, Mexico, Others)

  • Middle East and Africa

Competitive Landscape with Key Player:

  • Bausch Health Companies Inc.

  • Cipla Limited

  • Dr. Reddy's Laboratories

  • Galderma SA

  • GlaxoSmithKline PLC

  • Kaken Pharmaceutical Co. Ltd

  • Lumenis Ltd

  • Moberg Pharma AB

  • Novartis AG

  • Pfizer Inc

  • The OTC Lab B.V.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/onychomycosis-treatment-market

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Other Reports:

Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market

Thermoformed Plastics market Report: https://www.imarcgroup.com/thermoformed-plastics-market

Supply Chain Analytics Market Report: https://www.imarcgroup.com/supply-chain-analytics-market

Bicycle Market Report: https://www.imarcgroup.com/bicycle-market

AI in Fintech Market Report: https://www.imarcgroup.com/ai-in-fintech-market

Biological Safety Cabinet Market Report: https://www.imarcgroup.com/biological-safety-cabinet-market

Specialty Carbon Black Market Report: https://www.imarcgroup.com/specialty-carbon-black-market

Kosher Food Market Report: https://www.imarcgroup.com/kosher-food-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800